VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 61 filers reported holding VAXCYTE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $269,000 | -4.3% | 11,019 | -0.3% | 0.00% | – |
| Q4 2021 | $281,000 | -1.7% | 11,056 | +1.1% | 0.00% | – |
| Q3 2021 | $286,000 | +14.9% | 10,936 | +5.8% | 0.00% | – |
| Q2 2021 | $249,000 | +37.6% | 10,339 | +18.5% | 0.00% | – |
| Q1 2021 | $181,000 | -6.7% | 8,724 | +20.4% | 0.00% | – |
| Q4 2020 | $194,000 | +340.9% | 7,243 | +758.2% | 0.00% | – |
| Q3 2020 | $44,000 | – | 844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |